Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare ... (

Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference

Date:5/12/2008

- Presentation to be Webcast -

MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced today that Noah Berkowitz, M.D., Ph.D. President and Chief Executive Officer of Synvista will present at the upcoming Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 12:10 p.m. CEST (6:10 a.m. EDT). The event will be held from May 19-20, 2008 at the Le Meridien Beach Plaza Hotel in Monte Carlo.

Dr. Berkowitz will discuss the company's planned and/or ongoing Phase 2 initiatives for SYI-2074 (formerly ALT-2074) in cardiovascular diseases, alagebrium in heart failure and diabetic nephropathy and progress on the company's Haptoglobin diagnostic test. He will also provide an update of recent milestones and executive appointments.

The presentation will be simultaneously webcast and can be viewed live on the investor relations section of the Company's website at http://www.synvista.com . Participants are encouraged to log on to the webcast approximately five to ten minutes prior to the start of the presentation. It will be archived there after the event.

Note to Attendees: Synvista will be available for one-on-one meetings. Please arrange through Rodman & Renshaw or by calling Kim Sutton Golodetz or Jules Abraham at Lippert/Heilshorn & Associates at 212-838-3777.

The conference will feature presentations from more than 150 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. Details regarding t
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Synvista Therapeutics to Present at the BIO InvestorForum 2007
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
4. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
9. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
10. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
11. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007

Post Your Comments:

(Date:11/5/2009)...BURG, Md., Nov. 5 GenVec...ial results for the third quarter ended September ...on ($0.04 per share) for the three months ended Se...llion ($0.08 per share) in the comparable quarter ...009, GenVec,s net loss was $14.1 million ($0.15 pe...

(Date:11/5/2009)...ce Call on Thursday, November 5, 2009 at 4:30 p.m..... 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuti... OGXI ) today reported unaudited financial result...ember 30, 2009 and reviewed the Company,s highligh...ing consolidated results reflect the operations of...

(Date:11/5/2009)...O, CA, November 5, 2009 ...on using proprietary taste receptor-based technolo...food, beverage, and ingredient supply industries, ...ancial results for the third quarter ended Septemb...hird quarter of 2009, compared to $4.0 million for...

(Date:11/5/2009)... LASIK Surgery and vision correction ex...ry were actively involved at the recently conclude...ual Meeting in San Francisco, California. Dr. Step...Jonathan Davidorf, MD, Dr. Peter Rapoza, MD, Dr. M... Wayne Bowman, MD, Dr. Edward Manche, MD, and Dr. ...

[0] GenVec Reports Third Quarter 2009 Financial Results [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS [0] Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting

... Quality has been chosen to lead an effort to rep...ngs, but participation will not necessarily be bas...will be part of a federal pilot project to develop... from physician practices and present it in a form.... While the vision for this information exchange w...

...O Symposium , WTN caught up with Tom Koulopoulos f...,s a good idea. Read part one . , , WTN: You have... the risk of development to other organizations. B...h the loss of control? , , Koulopoulos Koulopo...cern is giving up control. We did some survey work...

...ected with the H5N1 avian influenza virus, mostly ... that the virus does not spread easily from its pi...omedical puzzle. , ,Now, a study of cells in the h... difference in the cells of the system that makes ...uman. , ,The finding, reported today (March 22) in...

Other Biology Technology:Healthcare quality initiative shuns high-tech for now 2 IT outsourcing according to Tom Koulopoulos, part 2 2 IT outsourcing according to Tom Koulopoulos, part 2 3 IT outsourcing according to Tom Koulopoulos, part 2 4 UW shows why avian flu hasn't spread among humans yet 2 UW shows why avian flu hasn't spread among humans yet 3

Healthcare quality initiative shuns high-tech for now IT outsourcing according to Tom Koulopoulos, part 2 UW shows why avian flu hasn't spread among humans yet

(Date:11/4/2009)...ctant to officially endorse green tea as a cancer ...t its protective effects, including results of a n..., a journal of the American Association for Cancer...ancer. , Vassiliki Papadimitrakopoulo, M.D., pr...Head and Neck Medical Oncology at the University o...

(Date:11/4/2009)...he DNA codes, or genomes, of the famed fugu (or pu...e 10K Project, an international effort to build an...species of animals for conducting comparative stud... , Participating in The Genome 10K project, desc...ue of the Journal of Heredity , are 70 leading sc...

(Date:11/4/2009)...rstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a leadin...software, today reported financial results for its...Michael Tzannes, Aware,s Chairman and Chief Execut... agreement to sell our DSL and home networking pro...company being spun out of Infineon. This transact...

Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2 Singapore scientists join international study of 10,000 vertebrates' genomes 2 Aware, Inc. Reports Third Quarter 2009 Financial Results 2 Aware, Inc. Reports Third Quarter 2009 Financial Results 3 Aware, Inc. Reports Third Quarter 2009 Financial Results 4 Aware, Inc. Reports Third Quarter 2009 Financial Results 5 Aware, Inc. Reports Third Quarter 2009 Financial Results 6 Aware, Inc. Reports Third Quarter 2009 Financial Results 7 aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 1 aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 2 MediZine Named in Intellectual Property Lawsuit Filed by Marketing Technology Solutions 58292 1 MediZine Named in Intellectual Property Lawsuit Filed by Marketing Technology Solutions 58292 2 UCI researchers create new strategy for highly selective chemotherapy delivery 58290 1 UCI researchers create new strategy for highly selective chemotherapy delivery 58290 2

[2] Does green tea prevent cancer? Evidence continues to brew, but questions remain [0] Singapore scientists join international study of 10,000 vertebrates' genomes [0] Aware, Inc. Reports Third Quarter 2009 Financial Results

... 26, 2009 / b3c newswire / - Cambridge Healthtech ...gress will be held May 27-29, 2009 at the Loews Ph...advance registration deadline for this event is Ap...ealthtech Institute,s Biomarker Series, The Biomar...ss.com ) is dedicated to all areas of biomarker re...

....--For the first time, MIT engineers and colleague... and subsequent migration of hundreds of millions ...cted using a novel imaging technique, "provides in...ecosystems that vast oceanic fish shoals inhabit,"... . , It also confirms theories about the behavior...

... a fast bite spelled doom for bony fishes during t...rding to a new study to be published March 31, 200...Sciences . , Today, those same features characte... billfishes, that are currently in decline and at ... author of the study and a graduate student in evo...

Other Biology News:CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 2 CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 3 CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 4 CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda 5 Team IDs genesis of mass migrations 2 Team IDs genesis of mass migrations 3 Study unravels why certain fishes went extinct 65 million years ago 2 Study unravels why certain fishes went extinct 65 million years ago 3

CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda Team IDs genesis of mass migrations Study unravels why certain fishes went extinct 65 million years ago

COX Chemiluminescence Assay Kit from Assay Designs/Stressgen Bioreagents

Goat Anti-p70 S6 Kinase, phospho (Thr229) Polyclonal Antibody, Unconjugated from R&D Systems

Sheep Growth Hormone from Cell Sciences

Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems

Biology Products:

COX Chemiluminescence Assay Kit from Assay Designs/Stressgen Bioreagents Goat Anti-p70 S6 Kinase, phospho (Thr229) Polyclonal Antibody, Unconjugated from R&D Systems Sheep Growth Hormone from Cell Sciences Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems

Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare ...( - Presentation...)